{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:44:05Z","timestamp":1787021045959,"version":"build-2736575974"},"reference-count":116,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T00:00:00Z","timestamp":1753660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T00:00:00Z","timestamp":1753660800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardio-Oncology"],"DOI":"10.1186\/s40959-025-00363-0","type":"journal-article","created":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T10:11:50Z","timestamp":1753697510000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Arrhythmias, conduction disorders and sudden cardiac death in cancer patients and survivors: expert opinion of the working groups on cardio-oncology and on electrophysiology of the hellenic cardiac society"],"prefix":"10.1186","volume":"11","author":[{"given":"Kalliopi","family":"Keramida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ourania","family":"Kariki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni","family":"Angelopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Kalafatis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos","family":"Lafaras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos P.","family":"Letsas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Michalopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios","family":"Saplaouras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Tampakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorothea","family":"Tsekoura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Andrikopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,28]]},"reference":[{"key":"363_CR1","doi-asserted-by":"publisher","first-page":"8985273","DOI":"10.1155\/2019\/8985273","volume":"2019","author":"M Yuan","year":"2019","unstructured":"Yuan M, Zhang Z, Tse G, Feng X, Korantzopoulos P, Letsas KP, et al. Association of Cancer and the Risk of Developing Atrial Fibrillation: A Systematic Review and Meta-Analysis. Cardiol Res Pract. 2019;2019:8985273.","journal-title":"Cardiol Res Pract"},{"issue":"1","key":"363_CR2","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1186\/s12885-019-6314-9","volume":"19","author":"CB Jakobsen","year":"2019","unstructured":"Jakobsen CB, Lamberts M, Carlson N, Lock-Hansen M, Torp-Pedersen C, Gislason GH, et al. Incidence of atrial fibrillation in different major cancer subtypes: a Nationwide population-based 12 year follow up study. BMC Cancer. 2019;19(1):1105.","journal-title":"BMC Cancer"},{"issue":"2","key":"363_CR3","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.jaccao.2021.03.006","volume":"3","author":"JP Yun","year":"2021","unstructured":"Yun JP, Choi EK, Han KD, Park SH, Jung JH, Park SH, et al. Risk of Atrial Fibrillation According to Cancer Type: A Nationwide Population-Based Study. JACC CardioOncology. 2021;3(2):221\u201332.","journal-title":"JACC CardioOncology"},{"issue":"1","key":"363_CR4","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.jacep.2016.03.001","volume":"3","author":"A Enriquez","year":"2017","unstructured":"Enriquez A, Biagi J, Redfearn D, Boles U, Kamel D, Ali FS, et al. Increased Incidence of Ventricular Arrhythmias in Patients With Advanced Cancer and Implantable Cardioverter-Defibrillators. JACC Clinical electrophysiology. 2017;3(1):50\u20136.","journal-title":"JACC Clinical electrophysiology"},{"issue":"41","key":"363_CR5","doi-asserted-by":"publisher","first-page":"4229","DOI":"10.1093\/eurheartj\/ehac244","volume":"43","author":"AR Lyon","year":"2022","unstructured":"Lyon AR, L\u00f3pez-Fern\u00e1ndez T, Couch LS, Asteggiano R, Aznar MC, Bergler-Klein J, et al. 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). Eur Heart J. 2022;43(41):4229\u2013361.","journal-title":"Eur Heart J"},{"issue":"10","key":"363_CR6","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1007\/s11912-023-01445-x","volume":"25","author":"M Gawlik","year":"2023","unstructured":"Gawlik M, Zimodro JM, G\u0105secka A, Filipiak KJ, Szmit S. Cardiac Arrhythmias in Oncological Patients-Epidemiology, Risk Factors, and Management within the Context of the New ESC 2022 Guidelines. Curr Oncol Rep. 2023;25(10):1107\u201315.","journal-title":"Curr Oncol Rep"},{"key":"363_CR7","doi-asserted-by":"crossref","unstructured":"Porta-S\u00e1nchez A, Gilbert C, Spears D, Amir E, Chan J, Nanthakumar K, Thavendiranathan P. Incidence, Diagnosis, and Management of QT Prolongation Induced by Cancer Therapies: A Systematic Review. J Am Heart Assoc. 2017 Dec 7;6(12):e007724. PMID: 29217664; PMCID: PMC5779062.","DOI":"10.1161\/JAHA.117.007724"},{"issue":"4","key":"363_CR8","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/j.jpainsymman.2019.12.356","volume":"59","author":"JR Hardy","year":"2020","unstructured":"Hardy JR, Bundock D, Cross J, Gibbons K, Pinkerton R, Kindl K, et al. Prevalence of QTc Prolongation in Patients With Advanced Cancer Receiving Palliative Care-A Cause for Concern? J Pain Symptom Manage. 2020;59(4):856\u201363.","journal-title":"J Pain Symptom Manage"},{"issue":"3","key":"363_CR9","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1055\/s-0041-1731907","volume":"10","author":"M Fonseca","year":"2021","unstructured":"Fonseca M, Cheng E, Do D, Haldar S, Kutty S, Yang EH, et al. Bradyarrhythmias in Cardio-Oncology. South Asian journal of cancer. 2021;10(3):195\u2013210.","journal-title":"South Asian journal of cancer"},{"issue":"4","key":"363_CR10","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1002\/cam4.622","volume":"5","author":"SH Ou","year":"2016","unstructured":"Ou SH, Tang Y, Polli A, Wilner KD, Schnell P. Factors associated with sinus bradycardia during crizotinib treatment: a retrospective analysis of two large-scale multinational trials (PROFILE 1005 and 1007). Cancer Med. 2016;5(4):617\u201322.","journal-title":"Cancer Med"},{"key":"363_CR11","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.lungcan.2021.08.014","volume":"161","author":"F Cirne","year":"2021","unstructured":"Cirne F, Zhou S, Kappel C, El-Kadi A, Barron CC, Ellis PM, et al. ALK inhibitor-induced bradycardia: A systematic-review and meta-analysis. Lung cancer (Amsterdam, Netherlands). 2021;161:9\u201317.","journal-title":"Lung cancer (Amsterdam, Netherlands)"},{"issue":"24","key":"363_CR12","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1016\/j.jacc.2009.02.050","volume":"53","author":"ET Yeh","year":"2009","unstructured":"Yeh ET, Bickford CL. Cardiovascular complications of cancer therapy: incidence, pathogenesis, diagnosis, and management. J Am Coll Cardiol. 2009;53(24):2231\u201347.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"363_CR13","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s10549-025-07671-0","volume":"211","author":"AL Sutton","year":"2025","unstructured":"Sutton AL, Zhao J, He J, Tossas KY, Bottinor W, Sheppard VB. Examining factors associated with experiencing cardiac arrhythmias in Black and White breast cancer survivors who received anthracyclines or trastuzumab. Breast Cancer Res Treat. 2025;211(2):537\u201344.","journal-title":"Breast Cancer Res Treat"},{"key":"363_CR14","unstructured":"Asteggiano R NC, Marengo S, Parrini I. Cancer and arrhythmias 2021 [Available from: https:\/\/www.escardio.org\/Journals\/E-Journal-of-Cardiology-Practice\/Volume-19\/cancer-and-arrhythmias."},{"issue":"3","key":"363_CR15","doi-asserted-by":"publisher","first-page":"113","DOI":"10.36401\/JIPO-20-10","volume":"3","author":"CC Simbaqueba","year":"2020","unstructured":"Simbaqueba CC, Aponte MP, Kim P, Deswal A, Palaskas NL, Iliescu C, et al. Cardiovascular Complications of Chimeric Antigen Receptor T-Cell Therapy: The Cytokine Release Syndrome and Associated Arrhythmias. Journal of immunotherapy and precision oncology. 2020;3(3):113\u201320.","journal-title":"Journal of immunotherapy and precision oncology"},{"issue":"2","key":"363_CR16","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.jacep.2016.08.009","volume":"3","author":"M Mazur","year":"2017","unstructured":"Mazur M, Wang F, Hodge DO, Siontis BL, Beinborn DS, Villarraga HR, et al. Burden of Cardiac Arrhythmias in Patients With Anthracycline-Related Cardiomyopathy. JACC Clinical electrophysiology. 2017;3(2):139\u201350.","journal-title":"JACC Clinical electrophysiology"},{"issue":"12","key":"363_CR17","first-page":"971","volume":"104","author":"PA Henriksen","year":"2018","unstructured":"Henriksen PA. Anthracycline cardiotoxicity: an update on mechanisms, monitoring and prevention. Heart (British Cardiac Society). 2018;104(12):971\u20137.","journal-title":"Heart (British Cardiac Society)"},{"issue":"3","key":"363_CR18","doi-asserted-by":"publisher","first-page":"e41","DOI":"10.1161\/CIR.0000000000000986","volume":"144","author":"MG Fradley","year":"2021","unstructured":"Fradley MG, Beckie TM, Brown SA, Cheng RK, Dent SF, Nohria A, et al. Recognition, Prevention, and Management of Arrhythmias and Autonomic Disorders in Cardio-Oncology: A Scientific Statement From the American Heart Association. Circulation. 2021;144(3):e41\u201355.","journal-title":"Circulation"},{"key":"363_CR19","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.pharmthera.2018.04.009","volume":"189","author":"J Alexandre","year":"2018","unstructured":"Alexandre J, Moslehi JJ, Bersell KR, Funck-Brentano C, Roden DM, Salem JE. Anticancer drug-induced cardiac rhythm disorders: Current knowledge and basic underlying mechanisms. Pharmacol Ther. 2018;189:89\u2013103.","journal-title":"Pharmacol Ther"},{"key":"363_CR20","doi-asserted-by":"publisher","unstructured":"Buza V, Rajagopalan B, Curtis AB. Cancer Treatment-Induced Arrhythmias: Focus on Chemotherapy and Targeted Therapies. Circ Arrhythm Electrophysiol. 2017;10(8):e005443. https:\/\/doi.org\/10.1161\/CIRCEP.117.005443. PMID: 28798022.","DOI":"10.1161\/CIRCEP.117.005443"},{"issue":"3","key":"363_CR21","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/0002-8703(94)90686-6","volume":"127","author":"K Ramireddy","year":"1994","unstructured":"Ramireddy K, Kane KM, Adhar GC. Acquired episodic complete heart block after high-dose chemotherapy with cyclophosphamide and thiotepa. Am Heart J. 1994;127(3):701\u20134.","journal-title":"Am Heart J"},{"issue":"5","key":"363_CR22","first-page":"430","volume":"62","author":"MA Khan","year":"2012","unstructured":"Khan MA, Masood N, Husain N, Ahmad B, Aziz T, Naeem A. A retrospective study of cardiotoxicities induced by 5-fluouracil (5-FU) and 5-FU based chemotherapy regimens in Pakistani adult cancer patients at Shaukat Khanum Memorial Cancer Hospital & Research Center. JPMA The Journal of the Pakistan Medical Association. 2012;62(5):430\u20134.","journal-title":"JPMA The Journal of the Pakistan Medical Association"},{"key":"363_CR23","first-page":"12","volume":"38","author":"\u00d6AK Yava\u015f","year":"2008","unstructured":"Yava\u015f \u00d6AK, \u00c7elik I. The prevalence of silent arrhythmia in patients receiving cisplatin-based chemotherapy. Turkish J Cancer. 2008;38:12\u20135.","journal-title":"Turkish J Cancer"},{"key":"363_CR24","doi-asserted-by":"publisher","first-page":"111620","DOI":"10.1016\/j.biopha.2021.111620","volume":"139","author":"N Siri-Angkul","year":"2021","unstructured":"Siri-Angkul N, Chattipakorn SC, Chattipakorn N. The mechanistic insights of the arrhythmogenic effect of trastuzumab. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2021;139:111620.","journal-title":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie."},{"key":"363_CR25","doi-asserted-by":"publisher","unstructured":"De Perna ML, Rigamonti E, Zannoni R, Espeli V, Moschovitis G. Immune Checkpoint Inhibitors and Cardiovascular Adverse Events. ESC Heart Fail. 2025. https:\/\/doi.org\/10.1002\/ehf2.15281. Epub ahead of print. PMID: 40205958.","DOI":"10.1002\/ehf2.15281"},{"key":"363_CR26","doi-asserted-by":"publisher","first-page":"986357","DOI":"10.3389\/fphar.2022.986357","volume":"13","author":"F Wang","year":"2022","unstructured":"Wang F, Wei Q, Wu X. Cardiac arrhythmias associated with immune checkpoint inhibitors: A comprehensive disproportionality analysis of the FDA adverse event reporting system. Front Pharmacol. 2022;13:986357.","journal-title":"Front Pharmacol"},{"issue":"6","key":"363_CR27","doi-asserted-by":"publisher","first-page":"6637","DOI":"10.1002\/cam4.5438","volume":"12","author":"Y Liu","year":"2023","unstructured":"Liu Y, Chen Y, Zeng Z, Liu A. Arrhythmic events associated with immune checkpoint inhibitors therapy: A real-world study based on the Food and Drug Administration Adverse Event Reporting System database. Cancer Med. 2023;12(6):6637\u201348.","journal-title":"Cancer Med"},{"key":"363_CR28","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.ejca.2022.07.019","volume":"174","author":"SR Thotamgari","year":"2022","unstructured":"Thotamgari SR, Grewal US, Nobel Bhuiyan MA, Abideen Asad ZU, Dominic P. The association of cardiac arrhythmias with chimeric antigen receptor T cell therapy in hospitalised patients: Insights from National Inpatient Sample. European journal of cancer (Oxford, England\u202f: 1990). 2022;174:131\u20133.","journal-title":"European journal of cancer (Oxford, England : 1990)."},{"issue":"25","key":"363_CR29","doi-asserted-by":"publisher","first-page":"3099","DOI":"10.1016\/j.jacc.2019.10.038","volume":"74","author":"RM Alvi","year":"2019","unstructured":"Alvi RM, Frigault MJ, Fradley MG, Jain MD, Mahmood SS, Awadalla M, et al. Cardiovascular Events Among Adults Treated With Chimeric Antigen Receptor T-Cells (CAR-T). J Am Coll Cardiol. 2019;74(25):3099\u2013108.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"363_CR30","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1093\/cvr\/cvz020","volume":"115","author":"M Barber","year":"2019","unstructured":"Barber M, Nguyen LS, Wassermann J, Spano JP, Funck-Brentano C, Salem JE. Cardiac arrhythmia considerations of hormone cancer therapies. Cardiovasc Res. 2019;115(5):878\u201394.","journal-title":"Cardiovasc Res"},{"issue":"3","key":"363_CR31","doi-asserted-by":"publisher","first-page":"e000082","DOI":"10.1161\/HCG.0000000000000082","volume":"14","author":"TM Okwuosa","year":"2021","unstructured":"Okwuosa TM, Morgans A, Rhee JW, Reding KW, Maliski S, Plana JC, et al. Impact of Hormonal Therapies for Treatment of Hormone-Dependent Cancers (Breast and Prostate) on the Cardiovascular System: Effects and Modifications: A Scientific Statement From the American Heart Association. Circulation Genomic and precision medicine. 2021;14(3):e000082.","journal-title":"Circulation Genomic and precision medicine"},{"key":"363_CR32","doi-asserted-by":"publisher","unstructured":"Grouthier V, Moey MYY, Gandjbakhch E, Waintraub X, Funck-Brentano C, Bachelot A, Salem JE. Sexual Dimorphisms, Anti-Hormonal Therapy and Cardiac Arrhythmias. Int J Mol Sci. 2021;22(3):1464. https:\/\/doi.org\/10.3390\/ijms22031464. PMID: 33540539; PMCID: PMC7867204.","DOI":"10.3390\/ijms22031464"},{"issue":"2","key":"363_CR33","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.jacasi.2023.09.014","volume":"4","author":"I Ho","year":"2024","unstructured":"Ho I, Wong CK, Wong YK, Lam TH, Sze-Him Leung I, Lin M, et al. Aromatase Inhibitor Therapy Increases the Risk of New-Onset Atrial Fibrillation in Patients With Breast Cancer. JACC Asia. 2024;4(2):150\u201360.","journal-title":"JACC Asia"},{"issue":"10","key":"363_CR34","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s11912-019-0841-z","volume":"21","author":"M Agarwal","year":"2019","unstructured":"Agarwal M, Canan T, Glover G, Thareja N, Akhondi A, Rosenberg J. Cardiovascular Effects of Androgen Deprivation Therapy in Prostate Cancer. Curr Oncol Rep. 2019;21(10):91.","journal-title":"Curr Oncol Rep"},{"issue":"10","key":"363_CR35","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/S1470-2045(12)70379-0","volume":"13","author":"K Fizazi","year":"2012","unstructured":"Fizazi K, Scher HI, Molina A, Logothetis CJ, Chi KN, Jones RJ, et al. Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study. Lancet Oncol. 2012;13(10):983\u201392.","journal-title":"Lancet Oncol"},{"issue":"4","key":"363_CR36","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1056\/NEJMoa1704174","volume":"377","author":"K Fizazi","year":"2017","unstructured":"Fizazi K, Tran N, Fein L, Matsubara N, Rodriguez-Antolin A, Alekseev BY, et al. Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer. N Engl J Med. 2017;377(4):352\u201360.","journal-title":"N Engl J Med"},{"issue":"2","key":"363_CR37","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/s41391-024-00886-0","volume":"28","author":"A Matsukawa","year":"2025","unstructured":"Matsukawa A, Yanagisawa T, Parizi MK, Laukhtina E, Klemm J, Fazekas T, et al. Cardiovascular events among men with prostate cancer treated with androgen receptor signaling inhibitors: a systematic review, meta-analysis, and network meta-analysis. Prostate Cancer Prostatic Dis. 2025;28(2):298\u2013308.","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"363_CR38","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.ejca.2017.07.003","volume":"84","author":"LHM Rydzewska","year":"2017","unstructured":"Rydzewska LHM, Burdett S, Vale CL, Clarke NW, Fizazi K, Kheoh T, et al. Adding abiraterone to androgen deprivation therapy in men with metastatic hormone-sensitive prostate cancer: A\u00a0systematic review and meta-analysis. European journal of cancer (Oxford, England\u202f: 1990). 2017;84:88\u2013101.","journal-title":"European journal of cancer (Oxford, England : 1990)."},{"issue":"4","key":"363_CR39","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.jaccao.2024.07.005","volume":"6","author":"KM Atkins","year":"2024","unstructured":"Atkins KM, Zhang SC, Kehayias C, Guthier C, He J, Gasho JO, et al. Cardiac Substructure Radiation Dose and Associations With Tachyarrhythmia and Bradyarrhythmia After Lung Cancer Radiotherapy. JACC CardioOncology. 2024;6(4):544\u201356.","journal-title":"JACC CardioOncology"},{"key":"363_CR40","doi-asserted-by":"publisher","first-page":"e24","DOI":"10.15420\/aer.2022.44","volume":"12","author":"R Bedi","year":"2023","unstructured":"Bedi R, Ahmad A, Horbal P, Mar PL. Radiation-associated Arrhythmias: Putative Pathophysiological Mechanisms, Prevalence, Screening and Management Strategies. Arrhythmia & electrophysiology review. 2023;12:e24.","journal-title":"Arrhythmia & electrophysiology review"},{"issue":"13","key":"363_CR41","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1200\/JCO.2016.71.6142","volume":"35","author":"RT Dess","year":"2017","unstructured":"Dess RT, Sun Y, Matuszak MM, Sun G, Soni PD, Bazzi L, et al. Cardiac Events After Radiation Therapy: Combined Analysis of Prospective Multicenter Trials for Locally Advanced Non-Small-Cell Lung Cancer. Journal of clinical oncology\u202f: official journal of the American Society of Clinical Oncology. 2017;35(13):1395\u2013402.","journal-title":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology"},{"issue":"3","key":"363_CR42","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1080\/07357907.2022.2027435","volume":"40","author":"S Saad","year":"2022","unstructured":"Saad S, Delouya G, Lambert C, Barkati M, Dariane C, Laskine M, et al. Prevalence and Risk Factors of QTc Prolongation in Prostate Cancer Patients Undergoing Brachytherapy. Cancer Invest. 2022;40(3):219\u201327.","journal-title":"Cancer Invest"},{"issue":"4","key":"363_CR43","doi-asserted-by":"publisher","first-page":"279","DOI":"10.7326\/0003-4819-129-4-199808150-00003","volume":"129","author":"CA Polanczyk","year":"1998","unstructured":"Polanczyk CA, Goldman L, Marcantonio ER, Orav EJ, Lee TH. Supraventricular arrhythmia in patients having noncardiac surgery: clinical correlates and effect on length of stay. Ann Intern Med. 1998;129(4):279\u201385.","journal-title":"Ann Intern Med"},{"issue":"3","key":"363_CR44","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1161\/CIRCULATIONAHA.110.011130","volume":"124","author":"S van Diepen","year":"2011","unstructured":"van Diepen S, Bakal JA, McAlister FA, Ezekowitz JA. Mortality and readmission of patients with heart failure, atrial fibrillation, or coronary artery disease undergoing noncardiac surgery: an analysis of 38 047 patients. Circulation. 2011;124(3):289\u201396.","journal-title":"Circulation"},{"issue":"10","key":"363_CR45","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.jacc.2013.11.026","volume":"63","author":"D Farmakis","year":"2014","unstructured":"Farmakis D, Parissis J, Filippatos G. Insights into onco-cardiology: atrial fibrillation in cancer. J Am Coll Cardiol. 2014;63(10):945\u201353.","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"363_CR46","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1016\/j.bbmt.2013.05.019","volume":"19","author":"A Singla","year":"2013","unstructured":"Singla A, Hogan WJ, Ansell SM, Buadi FK, Dingli D, Dispenzieri A, et al. Incidence of supraventricular arrhythmias during autologous peripheral blood stem cell transplantation. Biology of blood and marrow transplantation\u202f: journal of the American Society for Blood and Marrow Transplantation. 2013;19(8):1233\u20137.","journal-title":"Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation"},{"issue":"1","key":"363_CR47","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/bmt.2009.97","volume":"45","author":"E Peres","year":"2010","unstructured":"Peres E, Levine JE, Khaled YA, Ibrahim RB, Braun TM, Krijanovski OI, et al. Cardiac complications in patients undergoing a reduced-intensity conditioning hematopoietic stem cell transplantation. Bone Marrow Transplant. 2010;45(1):149\u201352.","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"363_CR48","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1002\/cncr.23281","volume":"112","author":"JA Jones","year":"2008","unstructured":"Jones JA, Qazilbash MH, Shih YC, Cantor SB, Cooksley CD, Elting LS. In-hospital complications of autologous hematopoietic stem cell transplantation for lymphoid malignancies: clinical and economic outcomes from the Nationwide Inpatient Sample. Cancer. 2008;112(5):1096\u2013105.","journal-title":"Cancer"},{"issue":"6","key":"363_CR49","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1177\/1753944712464102","volume":"6","author":"RK Sureddi","year":"2012","unstructured":"Sureddi RK, Amani F, Hebbar P, Williams DK, Leonardi M, Paydak H, et al. Atrial fibrillation following autologous stem cell transplantation in patients with multiple myeloma: incidence and risk factors. Ther Adv Cardiovasc Dis. 2012;6(6):229\u201336.","journal-title":"Ther Adv Cardiovasc Dis"},{"issue":"9","key":"363_CR50","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1038\/bmt.2015.127","volume":"50","author":"ES Tonorezos","year":"2015","unstructured":"Tonorezos ES, Stillwell EE, Calloway JJ, Glew T, Wessler JD, Rebolledo BJ, et al. Arrhythmias in the setting of hematopoietic cell transplants. Bone Marrow Transplant. 2015;50(9):1212\u20136.","journal-title":"Bone Marrow Transplant"},{"issue":"17","key":"363_CR51","doi-asserted-by":"publisher","first-page":"3129","DOI":"10.1182\/blood-2009-06-229369","volume":"116","author":"CL Sun","year":"2010","unstructured":"Sun CL, Francisco L, Kawashima T, Leisenring W, Robison LL, Baker KS, et al. Prevalence and predictors of chronic health conditions after hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study. Blood. 2010;116(17):3129\u201339377 quiz 377.","journal-title":"Blood."},{"issue":"1","key":"363_CR52","doi-asserted-by":"publisher","first-page":"21","DOI":"10.7326\/0003-4819-155-1-201107050-00004","volume":"155","author":"EJ Chow","year":"2011","unstructured":"Chow EJ, Mueller BA, Baker KS, Cushing-Haugen KL, Flowers ME, Martin PJ, et al. Cardiovascular hospitalizations and mortality among recipients of hematopoietic stem cell transplantation. Ann Intern Med. 2011;155(1):21\u201332.","journal-title":"Ann Intern Med"},{"issue":"2","key":"363_CR53","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/BF02226960","volume":"13","author":"R Martin","year":"1992","unstructured":"Martin R, Delgado JM, Molt\u00f2 JM, Vicent JM, Manzanares R, Insa R, et al. Cardiovascular reflexes in patients with malignant disease. Ital J Neurol Sci. 1992;13(2):125\u20139.","journal-title":"Ital J Neurol Sci"},{"issue":"6","key":"363_CR54","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1177\/2047487312452501","volume":"21","author":"M Woodward","year":"2014","unstructured":"Woodward M, Webster R, Murakami Y, Barzi F, Lam TH, Fang X, et al. The association between resting heart rate, cardiovascular disease and mortality: evidence from 112,680 men and women in 12 cohorts. Eur J Prev Cardiol. 2014;21(6):719\u201326.","journal-title":"Eur J Prev Cardiol"},{"issue":"3","key":"363_CR55","doi-asserted-by":"publisher","first-page":"E53","DOI":"10.1503\/cmaj.150535","volume":"188","author":"D Zhang","year":"2016","unstructured":"Zhang D, Shen X, Qi X. Resting heart rate and all-cause and cardiovascular mortality in the general population: a meta-analysis. CMAJ\u202f: Canadian Medical Association journal = journal de l\u2019Association medicale canadienne. 2016;188(3):E53-e63.","journal-title":"CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne."},{"issue":"11","key":"363_CR56","doi-asserted-by":"publisher","first-page":"2850","DOI":"10.1161\/01.CIR.94.11.2850","volume":"94","author":"H Tsuji","year":"1996","unstructured":"Tsuji H, Larson MG, Venditti FJ Jr, Manders ES, Evans JC, Feldman CL, et al. Impact of reduced heart rate variability on risk for cardiac events. The Framingham Heart Study Circulation. 1996;94(11):2850\u20135.","journal-title":"The Framingham Heart Study Circulation"},{"issue":"18","key":"363_CR57","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1056\/NEJM199910283411804","volume":"341","author":"CR Cole","year":"1999","unstructured":"Cole CR, Blackstone EH, Pashkow FJ, Snader CE, Lauer MS. Heart-rate recovery immediately after exercise as a predictor of mortality. N Engl J Med. 1999;341(18):1351\u20137.","journal-title":"N Engl J Med"},{"issue":"8","key":"363_CR58","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s11886-018-1010-y","volume":"20","author":"BGT Coumbe","year":"2018","unstructured":"Coumbe BGT, Groarke JD. Cardiovascular Autonomic Dysfunction in Patients with Cancer. Curr Cardiol Rep. 2018;20(8):69.","journal-title":"Curr Cardiol Rep"},{"issue":"2","key":"363_CR59","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.ahj.2015.05.014","volume":"170","author":"SG Lakoski","year":"2015","unstructured":"Lakoski SG, Jones LW, Krone RJ, Stein PK, Scott JM. Autonomic dysfunction in early breast cancer: Incidence, clinical importance, and underlying mechanisms. Am Heart J. 2015;170(2):231\u201341.","journal-title":"Am Heart J"},{"issue":"5","key":"363_CR60","doi-asserted-by":"publisher","first-page":"e20424","DOI":"10.1371\/journal.pone.0020424","volume":"6","author":"C M\u00fchlfeld","year":"2011","unstructured":"M\u00fchlfeld C, Das SK, Heinzel FR, Schmidt A, Post H, Schauer S, et al. Cancer induces cardiomyocyte remodeling and hypoinnervation in the left ventricle of the mouse heart. PLoS ONE. 2011;6(5):e20424.","journal-title":"PLoS ONE"},{"issue":"2","key":"363_CR61","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.biopsycho.2005.11.013","volume":"74","author":"JF Thayer","year":"2007","unstructured":"Thayer JF, Lane RD. The role of vagal function in the risk for cardiovascular disease and mortality. Biol Psychol. 2007;74(2):224\u201342.","journal-title":"Biol Psychol"},{"issue":"15","key":"363_CR62","doi-asserted-by":"publisher","first-page":"e811","DOI":"10.1161\/CIR.0000000000001056","volume":"145","author":"CJ Beavers","year":"2022","unstructured":"Beavers CJ, Rodgers JE, Bagnola AJ, Beckie TM, Campia U, Di Palo KE, et al. Cardio-Oncology Drug Interactions: A Scientific Statement From the American Heart Association. Circulation. 2022;145(15):e811\u201338.","journal-title":"Circulation"},{"key":"363_CR63","doi-asserted-by":"publisher","first-page":"102822","DOI":"10.1016\/j.critrevonc.2019.102822","volume":"145","author":"M Akbulut","year":"2020","unstructured":"Akbulut M, Urun Y. Onco-cardiology: Drug-drug interactions of antineoplastic and cardiovascular drugs. Crit Rev Oncol Hematol. 2020;145:102822.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"3","key":"363_CR64","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1111\/bjh.14324","volume":"175","author":"PA Thompson","year":"2016","unstructured":"Thompson PA, L\u00e9vy V, Tam CS, Al Nawakil C, Goudot FX, Quinquenel A, et al. Atrial fibrillation in CLL patients treated with ibrutinib. An international retrospective study. British journal of haematology. 2016;175(3):462\u20136.","journal-title":"British journal of haematology."},{"issue":"1","key":"363_CR65","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.hemonc.2021.06.001","volume":"15","author":"T Al-Tweigeri","year":"2022","unstructured":"Al-Tweigeri T, Dent S, Al Sayed A, Mohty D, Suleman K, Ajarim D, et al. Using the Appropriate Formula for QT Measurement Can Save Lives. Hematol Oncol Stem Cell Ther. 2022;15(1):79\u201382.","journal-title":"Hematol Oncol Stem Cell Ther"},{"issue":"17","key":"363_CR66","doi-asserted-by":"publisher","first-page":"e009543","DOI":"10.1161\/JAHA.118.009543","volume":"7","author":"N Vinter","year":"2018","unstructured":"Vinter N, Christesen AMS, Fenger-Gr\u00f8n M, Tj\u00f8nneland A, Frost L. Atrial Fibrillation and Risk of Cancer: A Danish Population-Based Cohort Study. J Am Heart Assoc. 2018;7(17):e009543.","journal-title":"J Am Heart Assoc"},{"key":"363_CR67","doi-asserted-by":"publisher","unstructured":"Semeraro GC, Meroni CA, Cipolla CM, Cardinale DM. Atrial Fibrillation after Lung Cancer Surgery: Prediction, Prevention and Anticoagulation Management. Cancers (Basel). 2021;13(16):4012. https:\/\/doi.org\/10.3390\/cancers13164012. PMID: 34439166; PMCID: PMC8394120.","DOI":"10.3390\/cancers13164012"},{"issue":"1","key":"363_CR68","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s43057-023-00109-7","volume":"31","author":"V Scheggi","year":"2023","unstructured":"Scheggi V, Menale S, Marcucci R, Dematt\u00e9 A, Giovacchini J, Cenni N, et al. Postoperative atrial fibrillation after thoracic surgery (PoAF): risk factors and outcome. The Cardiothoracic Surgeon. 2023;31(1):18.","journal-title":"The Cardiothoracic Surgeon"},{"key":"363_CR69","doi-asserted-by":"publisher","first-page":"867002","DOI":"10.3389\/fcvm.2022.867002","volume":"9","author":"M Murtaza","year":"2022","unstructured":"Murtaza M, Baig MMA, Ahmed J, Serbanoiu LI, Busnatu SS. Higher Mortality Associated With New-Onset Atrial Fibrillation in Cancer Patients: A Systematic Review and Meta-Analysis. Frontiers in cardiovascular medicine. 2022;9:867002.","journal-title":"Frontiers in cardiovascular medicine"},{"key":"363_CR70","unstructured":"Farooqui M VJ, Soto S, Bray A, Tian X, Wiestner A. Atrial fibrillation in CLL\/SLL patients on ibrutinib. . Presented at: American Society of Hematology (ASH) 57th Annual Meeting; December 5\u20138, 2015;Orlando, FL; 2015."},{"issue":"4","key":"363_CR71","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1093\/ehjcvp\/pvaa059","volume":"7","author":"K Keramida","year":"2021","unstructured":"Keramida K, Filippatos G, Farmakis D. Cancer treatment and atrial fibrillation: use of pharmacovigilance databases to detect cardiotoxicity. European heart journal Cardiovascular pharmacotherapy. 2021;7(4):321\u20133.","journal-title":"European heart journal Cardiovascular pharmacotherapy"},{"issue":"5","key":"363_CR72","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"G Hindricks","year":"2021","unstructured":"Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomstr\u00f6m-Lundqvist C, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021;42(5):373\u2013498.","journal-title":"Eur Heart J"},{"issue":"2","key":"363_CR73","doi-asserted-by":"publisher","first-page":"100096","DOI":"10.1016\/j.rpth.2023.100096","volume":"7","author":"G Chu","year":"2023","unstructured":"Chu G, Seelig J, Cannegieter SC, Gelderblom H, Hovens MMC, Huisman MV, et al. Atrial fibrillation in cancer: thromboembolism and bleeding in daily practice. Research and practice in thrombosis and haemostasis. 2023;7(2):100096.","journal-title":"Research and practice in thrombosis and haemostasis"},{"issue":"2","key":"363_CR74","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.jaccao.2022.08.014","volume":"5","author":"A Leader","year":"2023","unstructured":"Leader A, Mendelson Cohen N, Afek S, Jaschek R, Frajman A, Itzhaki Ben Zadok O, et al. Arterial Thromboembolism in Patients With AF and CHA(2)DS(2)-VASc Score 0\u20132 With and Without Cancer. JACC Cardio Oncology. 2023;5(2):174\u201385.","journal-title":"JACC Cardio Oncology."},{"key":"363_CR75","doi-asserted-by":"publisher","first-page":"101072","DOI":"10.1016\/j.ijcha.2022.101072","volume":"41","author":"B Bungo","year":"2022","unstructured":"Bungo B, Chaudhury P, Arustamyan M, Rikhi R, Hussain M, Collier P, et al. Better prediction of stroke in atrial fibrillation with incorporation of cancer in CHA(2)DS(2)VASC score: CCHA(2)DS(2)VASC score. International journal of cardiology Heart & vasculature. 2022;41:101072.","journal-title":"International journal of cardiology Heart & vasculature"},{"issue":"11","key":"363_CR76","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1056\/NEJMoa1107039","volume":"365","author":"CB Granger","year":"2011","unstructured":"Granger CB, Alexander JH, McMurray JJ, Lopes RD, Hylek EM, Hanna M, et al. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2011;365(11):981\u201392.","journal-title":"N Engl J Med"},{"issue":"10","key":"363_CR77","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1056\/NEJMoa1009638","volume":"365","author":"MR Patel","year":"2011","unstructured":"Patel MR, Mahaffey KW, Garg J, Pan G, Singer DE, Hacke W, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med. 2011;365(10):883\u201391.","journal-title":"N Engl J Med"},{"issue":"22","key":"363_CR78","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","volume":"369","author":"RP Giugliano","year":"2013","unstructured":"Giugliano RP, Ruff CT, Braunwald E, Murphy SA, Wiviott SD, Halperin JL, et al. Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2013;369(22):2093\u2013104.","journal-title":"N Engl J Med"},{"issue":"12","key":"363_CR79","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1016\/j.amjmed.2017.06.026","volume":"130","author":"C Melloni","year":"2017","unstructured":"Melloni C, Dunning A, Granger CB, Thomas L, Khouri MG, Garcia DA, et al. Efficacy and Safety of Apixaban Versus Warfarin in Patients with Atrial Fibrillation and a History of Cancer: Insights from the ARISTOTLE Trial. Am J Med. 2017;130(12):1440-8.e1.","journal-title":"Am J Med"},{"issue":"2","key":"363_CR80","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1093\/ehjqcco\/qcy040","volume":"5","author":"ST Chen","year":"2019","unstructured":"Chen ST, Hellkamp AS, Becker RC, Berkowitz SD, Breithardt G, Fox KAA, et al. Efficacy and safety of rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation and a history of cancer: observations from ROCKET AF. European heart journal Quality of care & clinical outcomes. 2019;5(2):145\u201352.","journal-title":"European heart journal Quality of care & clinical outcomes."},{"issue":"16","key":"363_CR81","doi-asserted-by":"publisher","first-page":"e008987","DOI":"10.1161\/JAHA.118.008987","volume":"7","author":"CL Fanola","year":"2018","unstructured":"Fanola CL, Ruff CT, Murphy SA, Jin J, Duggal A, Babilonia NA, et al. Efficacy and Safety of Edoxaban in Patients With Active Malignancy and Atrial Fibrillation: Analysis of the ENGAGE AF - TIMI 48 Trial. J Am Heart Assoc. 2018;7(16):e008987.","journal-title":"J Am Heart Assoc"},{"issue":"14","key":"363_CR82","doi-asserted-by":"publisher","first-page":"e012540","DOI":"10.1161\/JAHA.119.012540","volume":"8","author":"Y Deng","year":"2019","unstructured":"Deng Y, Tong Y, Deng Y, Zou L, Li S, Chen H. Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients With Cancer and Atrial Fibrillation: A Systematic Review and Meta-Analysis. J Am Heart Assoc. 2019;8(14):e012540.","journal-title":"J Am Heart Assoc"},{"key":"363_CR83","doi-asserted-by":"publisher","first-page":"766377","DOI":"10.3389\/fcvm.2021.766377","volume":"8","author":"F Liu","year":"2021","unstructured":"Liu F, Xu Z, Luo J, Yu P, Ma J, Yuan P, et al. Effectiveness and Safety of DOACs vs. VKAs in AF Patients With Cancer: Evidence From Randomized Clinical Trials and Observational Studies. Frontiers in cardiovascular medicine. 2021;8:766377.","journal-title":"Frontiers in cardiovascular medicine."},{"key":"363_CR84","doi-asserted-by":"publisher","first-page":"100144","DOI":"10.1016\/j.tru.2023.100144","volume":"12","author":"LA Ciuffini","year":"2023","unstructured":"Ciuffini LA, Delluc A, Wang TF, Lodigiani C, Carrier M. Evaluating efficacy and safety of oral anticoagulation in adult patients with atrial fibrillation and cancer: A systemic review and meta-analysis. Thrombosis Update. 2023;12:100144.","journal-title":"Thrombosis Update"},{"issue":"10","key":"363_CR85","doi-asserted-by":"publisher","first-page":"8559","DOI":"10.1007\/s00520-022-07235-8","volume":"30","author":"N Tsoukalas","year":"2022","unstructured":"Tsoukalas N, Brito-Dellan N, Font C, Butler T, Rojas-Hernandez CM, Butler T, et al. Complexity and clinical significance of drug-drug interactions (DDIs) in oncology: challenging issues in the care of patients regarding cancer-associated thrombosis (CAT). Supportive care in cancer\u202f: official journal of the Multinational Association of Supportive Care in Cancer. 2022;30(10):8559\u201373.","journal-title":"Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer"},{"key":"363_CR86","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s40959-017-0021-y","volume":"3","author":"A Asnani","year":"2017","unstructured":"Asnani A, Manning A, Mansour M, Ruskin J, Hochberg EP, Ptaszek LM. Management of atrial fibrillation in patients taking targeted cancer therapies. Cardio-oncology (London, England). 2017;3:2.","journal-title":"Cardio-oncology (London, England)"},{"key":"363_CR87","doi-asserted-by":"publisher","unstructured":"Garibaldi S, Chianca M, Fabiani I, Emdin M, Piacenti M, Passino C, Aimo A, Fedele A, Cipolla CM, Cardinale DM. Treatment Options in AF Patients with Cancer; Focus on Catheter Ablation. J Clin Med. 2022;11(15):4452. https:\/\/doi.org\/10.3390\/jcm11154452. PMID: 35956068; PMCID: PMC9369260.","DOI":"10.3390\/jcm11154452"},{"issue":"3","key":"363_CR88","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s10840-020-00745-7","volume":"60","author":"M Giustozzi","year":"2021","unstructured":"Giustozzi M, Ali H, Reboldi G, Balla C, Foresti S, de Ambroggi G, et al. Safety of catheter ablation of atrial fibrillation in cancer survivors. Journal of interventional cardiac electrophysiology\u202f: an international journal of arrhythmias and pacing. 2021;60(3):419\u201326.","journal-title":"Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing"},{"key":"363_CR89","doi-asserted-by":"publisher","unstructured":"Eitel C, Sciacca V, Bartels N, Saraei R, Fink T, Keelani A, Ga\u00dfmann A, Kuck KH, Vogler J, Heeger CH, Tilz RR. Safety and Efficacy of Cryoballoon Based Pulmonary Vein Isolation in Patients with Atrial Fibrillation and a History of Cancer. J Clin Med. 2021;10(16):3669. https:\/\/doi.org\/10.3390\/jcm10163669. PMID: 34441965; PMCID: PMC8397043.","DOI":"10.3390\/jcm10163669"},{"issue":"1","key":"363_CR90","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40959-023-00171-4","volume":"9","author":"S Ganatra","year":"2023","unstructured":"Ganatra S, Abraham S, Kumar A, Parikh R, Patel R, Khadke S, et al. Efficacy and safety of catheter ablation for atrial fibrillation in patients with history of cancer. Cardio-oncology (London, England). 2023;9(1):19.","journal-title":"Cardio-oncology (London, England)"},{"key":"363_CR91","doi-asserted-by":"publisher","first-page":"613625","DOI":"10.3389\/fcvm.2021.613625","volume":"8","author":"P Kim","year":"2021","unstructured":"Kim P, Masha L, Olson A, Iliescu C, Karimzad K, Hassan S, et al. QT Prolongation in Cancer Patients. Frontiers in cardiovascular medicine. 2021;8:613625.","journal-title":"Frontiers in cardiovascular medicine"},{"issue":"25","key":"363_CR92","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1093\/eurheartj\/ehae222","volume":"45","author":"Q Chen","year":"2024","unstructured":"Chen Q, van Rein N, van der Hulle T, Heemelaar JC, Trines SA, Versteeg HH, et al. Coexisting atrial fibrillation and cancer: time trends and associations with mortality in a nationwide Dutch study. Eur Heart J. 2024;45(25):2201\u201313.","journal-title":"Eur Heart J"},{"issue":"40","key":"363_CR93","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.1093\/eurheartj\/ehac262","volume":"43","author":"K Zeppenfeld","year":"2022","unstructured":"Zeppenfeld K, Tfelt-Hansen J, de Riva M, Winkel BG, Behr ER, Blom NA, et al. 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J. 2022;43(40):3997\u20134126.","journal-title":"Eur Heart J"},{"issue":"1","key":"363_CR94","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s40959-024-00271-9","volume":"10","author":"CH Chan","year":"2024","unstructured":"Chan CH, Liu CM, Chen PF, Liao LL, Wu IC, Hu YF. Association between QT prolongation and cardiovascular mortality in cancer patients. Cardio-oncology (London, England). 2024;10(1):69.","journal-title":"Cardio-oncology (London, England)"},{"issue":"4","key":"363_CR95","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1093\/eurheartj\/ehab674","volume":"43","author":"J Herrmann","year":"2022","unstructured":"Herrmann J, Lenihan D, Armenian S, Barac A, Blaes A, Cardinale D, et al. Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement. Eur Heart J. 2022;43(4):280\u201399.","journal-title":"Eur Heart J"},{"issue":"1","key":"363_CR96","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.jaccao.2021.01.002","volume":"3","author":"PY Kim","year":"2021","unstructured":"Kim PY, Irizarry-Caro JA, Ramesh T, Iliescu C, Lopez-Mattei JC. How to Diagnose and Manage QT Prolongation in Cancer Patients. JACC CardioOncology. 2021;3(1):145\u20139.","journal-title":"JACC CardioOncology"},{"issue":"6","key":"363_CR97","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1007\/s00432-019-02927-x","volume":"145","author":"SA Atallah-Yunes","year":"2019","unstructured":"Atallah-Yunes SA, Kadado AJ, Kaufman GP, Hernandez-Montfort J. Immune checkpoint inhibitor therapy and myocarditis: a systematic review of reported cases. J Cancer Res Clin Oncol. 2019;145(6):1527\u201357.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"18","key":"363_CR98","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1161\/CIRCULATIONAHA.121.055816","volume":"144","author":"JR Power","year":"2021","unstructured":"Power JR, Alexandre J, Choudhary A, Ozbay B, Hayek S, Asnani A, et al. Electrocardiographic Manifestations of Immune Checkpoint Inhibitor Myocarditis. Circulation. 2021;144(18):1521\u20133.","journal-title":"Circulation"},{"issue":"2","key":"363_CR99","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s40264-021-01132-5","volume":"45","author":"J Tamargo","year":"2022","unstructured":"Tamargo J, Caballero R, Delp\u00f3n E. Cancer Chemotherapy-Induced Sinus Bradycardia: A Narrative Review of a Forgotten Adverse Effect of Cardiotoxicity. Drug Saf. 2022;45(2):101\u201326.","journal-title":"Drug Saf"},{"issue":"8","key":"363_CR100","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1016\/j.jcmg.2018.04.028","volume":"11","author":"MY Desai","year":"2018","unstructured":"Desai MY, Jellis CL, Kotecha R, Johnston DR, Griffin BP. Radiation-Associated Cardiac Disease: A Practical Approach to Diagnosis and Management. JACC Cardiovasc Imaging. 2018;11(8):1132\u201349.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"18","key":"363_CR101","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1001\/jama.2019.16658","volume":"322","author":"JP Singh","year":"2019","unstructured":"Singh JP, Solomon SD, Fradley MG, Barac A, Kremer KA, Beck CA, et al. Association of Cardiac Resynchronization Therapy With Change in Left Ventricular Ejection Fraction in Patients With Chemotherapy-Induced Cardiomyopathy. JAMA. 2019;322(18):1799\u2013805.","journal-title":"JAMA"},{"issue":"2","key":"363_CR102","doi-asserted-by":"publisher","first-page":"e000701","DOI":"10.1136\/openhrt-2017-000701","volume":"4","author":"MG Fradley","year":"2017","unstructured":"Fradley MG, Viganego F, Kip K, Martin A, Patel AA, Ismail-Khan R, et al. Rates and risk of arrhythmias in cancer survivors with chemotherapy-induced cardiomyopathy compared with patients with other cardiomyopathies. Open heart. 2017;4(2):e000701.","journal-title":"Open heart"},{"key":"363_CR103","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.amjcard.2023.12.012","volume":"214","author":"S Sherazi","year":"2024","unstructured":"Sherazi S, Patel A, Hsu K, Schleede S, Watts A, McNitt S, et al. Risk of Sudden Cardiac Death in Patients Undergoing Cancer Treatment. Am J Cardiol. 2024;214:136\u201341.","journal-title":"Am J Cardiol"},{"key":"363_CR104","doi-asserted-by":"publisher","unstructured":"M Mirabel, J.S Hulot, A Lillo-Lelouet, X Jouven, E Marijon, Sudden cardiac death in cancer patients: results from the Paris-Sudden Death Expertise Centre. Eur Heart J. 2020;41(Supplement_2):ehaa946.3565. https:\/\/doi.org\/10.1093\/ehjci\/ehaa946.3565.","DOI":"10.1093\/ehjci\/ehaa946.3565"},{"issue":"16","key":"363_CR105","first-page":"1022","volume":"110","author":"O Weizman","year":"2024","unstructured":"Weizman O, Eslami A, Bougouin W, Beganton F, Lamhaut L, Jost D, et al. Sudden cardiac arrest in patients with cancer in the general population: insights from the Paris-SDEC registry. Heart (British Cardiac Society). 2024;110(16):1022\u20139.","journal-title":"Heart (British Cardiac Society)"},{"issue":"11","key":"363_CR106","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1001\/jamaoncol.2021.4771","volume":"7","author":"JM Bonsu","year":"2021","unstructured":"Bonsu JM, Kola-Kehinde O, Kim L, Ruz P, Campbell CM, Brammer JE, et al. Cardiovascular Safety Communications After US Food and Drug Administration Approval of Contemporary Cancer Therapies. JAMA Oncol. 2021;7(11):1722\u20133.","journal-title":"JAMA Oncol"},{"issue":"4","key":"363_CR107","first-page":"459","volume":"37","author":"I Rhea","year":"2019","unstructured":"Rhea I, Burgos PH, Fradley MG. Arrhythmogenic Anticancer Drugs in Cardio-Oncology. Cardiol Clin. 2019;37(4):459\u201368.","journal-title":"Cardiol Clin"},{"issue":"2","key":"363_CR108","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1159\/000528019","volume":"68","author":"G Boriani","year":"2023","unstructured":"Boriani G, Menna P, Morgagni R, Minotti G, Vitolo M. Ibrutinib and Bruton\u2019s Tyrosine Kinase Inhibitors in Chronic Lymphocytic Leukemia: Focus on Atrial Fibrillation and Ventricular Tachyarrhythmias\/Sudden Cardiac Death. Chemotherapy. 2023;68(2):61\u201372.","journal-title":"Chemotherapy"},{"issue":"2","key":"363_CR109","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.ccep.2015.03.013","volume":"7","author":"MG Fradley","year":"2015","unstructured":"Fradley MG, Moslehi J. QT Prolongation and Oncology Drug Development. Cardiac electrophysiology clinics. 2015;7(2):341\u201355.","journal-title":"Cardiac electrophysiology clinics"},{"issue":"7","key":"363_CR110","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1002\/1097-0142(20011001)92:7<1905::AID-CNCR1708>3.0.CO;2-6","volume":"92","author":"MS Ewer","year":"2001","unstructured":"Ewer MS, Kish SK, Martin CG, Price KJ, Feeley TW. Characteristics of cardiac arrest in cancer patients as a predictor of survival after cardiopulmonary resuscitation. Cancer. 2001;92(7):1905\u201312.","journal-title":"Cancer"},{"issue":"2","key":"363_CR111","doi-asserted-by":"publisher","first-page":"e30353","DOI":"10.1371\/journal.pone.0030353","volume":"7","author":"J Zang","year":"2012","unstructured":"Zang J, Wu S, Tang L, Xu X, Bai J, Ding C, et al. Incidence and risk of QTc interval prolongation among cancer patients treated with vandetanib: a systematic review and meta-analysis. PLoS ONE. 2012;7(2):e30353.","journal-title":"PLoS ONE"},{"issue":"11","key":"363_CR112","doi-asserted-by":"publisher","first-page":"3160","DOI":"10.1002\/ijc.33119","volume":"147","author":"AA Abu Rmilah","year":"2020","unstructured":"Abu Rmilah AA, Lin G, Begna KH, Friedman PA, Herrmann J. Risk of QTc prolongation among cancer patients treated with tyrosine kinase inhibitors. Int J Cancer. 2020;147(11):3160\u20137.","journal-title":"Int J Cancer"},{"issue":"4","key":"363_CR113","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/joim.13709","volume":"294","author":"A Edsj\u00f6","year":"2023","unstructured":"Edsj\u00f6 A, Holmquist L, Geoerger B, Nowak F, Gomon G, Alix-Panabi\u00e8res C, et al. Precision cancer medicine: Concepts, current practice, and future developments. J Intern Med. 2023;294(4):455\u201381.","journal-title":"J Intern Med"},{"key":"363_CR114","doi-asserted-by":"publisher","unstructured":"Hawryszko M, S\u0142awi\u0144ski G, Tomasik B, Lewicka E. Cardiac Arrhythmias in Patients Treated for Lung Cancer: A Review. Cancers (Basel). 2023;15(24):5723. https:\/\/doi.org\/10.3390\/cancers15245723. PMID: 38136269; PMCID: PMC10741954.","DOI":"10.3390\/cancers15245723"},{"issue":"3","key":"363_CR115","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s00399-024-01033-x","volume":"35","author":"K Iliodromitis","year":"2024","unstructured":"Iliodromitis K, Hoiczyk M, Bimpong-Buta NY, Seyfarth M, Bogossian H. Arrhythmias in oncological patients: a compact overview for the clinician. Herzschrittmacherther Elektrophysiol. 2024;35(3):177\u201382.","journal-title":"Herzschrittmacherther Elektrophysiol"},{"key":"363_CR116","doi-asserted-by":"publisher","unstructured":"Mandala E, Lafara K, Kokkinovasilis D, Kalafatis I, Koukoulitsa V, Katodritou E, Lafaras C. Applied Cardio-Oncology in Hematological Malignancies: A Narrative Review. Life (Basel). 2024;14(4):524. https:\/\/doi.org\/10.3390\/life14040524. PMID: 38672794; PMCID: PMC11050930.","DOI":"10.3390\/life14040524"}],"container-title":["Cardio-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40959-025-00363-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40959-025-00363-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40959-025-00363-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T04:44:00Z","timestamp":1757306640000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiooncologyjournal.biomedcentral.com\/articles\/10.1186\/s40959-025-00363-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,28]]},"references-count":116,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["363"],"URL":"https:\/\/doi.org\/10.1186\/s40959-025-00363-0","relation":{},"ISSN":["2057-3804"],"issn-type":[{"value":"2057-3804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,28]]},"assertion":[{"value":"20 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Following the article's publication, an error was found in the Funding section. This has been corrected.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"(applicable\u00a0for both human and\/or animal studies. Ethical committees, Internal Review Boards and guidelines followed must be named.\u00a0When applicable, additional headings\u00a0with statements on\u00a0consent to participate\u00a0and\u00a0consent to publish\u00a0are also required).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"71"}}